Sign in
CompletedNo phase

Benefits of Jing-Si-Herbal-Tea in Bronchiectasis

Key facts

Who runs it
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
25 people enrolled
Started
1 Jan 2024
Ended
31 Dec 2024
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Jing-Si Herbal Tea
  • Placebo
Record updated
30 March 2025

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age 18 years or older
  • Clinically diagnosed with bronchiectasis
  • Willing to participate in the study
  • Signed an informed consent form

Who cannot take part

  • Individuals with severe kidney diseases
  • Pregnant or breastfeeding women
  • Individuals with severe liver
  • Individuals who refuse to participate in the study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Patients are divided into two groups: the usual care group (UC group) and the Jing-Si Herbal Tea group (JSHT group).

Read full original descriptionShow less

* **UC Group**: Receives standard treatment and one placebo packet daily for three months. * **JSHT Group**: Receives standard treatment plus one packet of Jing-Si Herbal Tea daily for three months.

Each group includes 30 participants. The study runs from January 1, 2014, to December 31, 2014. Exclusions include severe liver or renal dysfunction and allergy to Jing-Si Herbal Tea. Participants must follow the study protocol.

**Assessments**:

* **HRQL**: Measured using the COPD Assessment Test (CAT) and the Modified Medical Research Council (mMRC) scale. * **Blood Tests**: Include WBCs, hemoglobin, hematocrit, platelets, BUN, creatinine, uric acid, liver enzymes, electrolytes, CRP, and pPro-BNP. Blood samples will also be analyzed for DAMPs and inflammatory cytokines. * **Pulmonary Function Tests (PFT)**: Conducted with a spirometer per American Thoracic Society guidelines.

The 2 groups in the trial

  • usual care group (UC group)Placebo, for comparison

    The UC group will receive standard medical treatment, with one placebo packet daily for three months.

    Treatment: Placebo

  • Jing-Si Herbal Tea group (JSHT group)Treatment being tested

    The JSHT group will receive the standard medical treatment along with Jing-Si Herbal Tea, one packet daily for three months.

    Treatment: Jing-Si Herbal Tea

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
30 March 2025